CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 40 enrolled
Drug / intervention
Miconaz oral gel +4 moredrug
Likely dose
Rapid Release Capsules Melatonin, 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03833570
NCT03833570Phase 2Completed

The Effectiveness of Melatonin in Prevention of Radiation-induced Oral Mucositis

Hams Hamed Abdelrahman·interventional·Posted Feb 7, 2019·Updated Jun 17, 2019

In Brief

A Phase 2 clinical trial evaluating Rapid Release Capsules Melatonin, 10 mg, Miconaz oral gel, and 3 other interventions for Oral Mucositis (Ulcerative) Due to Radiation. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The main aim of this study was to evaluate the effectiveness of melatonin in prevention of radiation induced oral mucositis clinically and biochemically.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedFeb 7, 2019
Enrollment StartJan 12, 2018
Primary CompletionNov 9, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 7.4 years ago

Interventions

Rapid Release Capsules Melatonin, 10 mgdietary

Melatonin is a dietary supplement which is naturally produced in the body and closely involved in the natural sleep cycle. recently topical and systemic melatonin supplements. have been proposed as a new therapeutic modality for oral mucositis due to its anti-cancer, anti-inflammatory, and anti-oxidant effects.

Miconaz oral geldrug

Antifungal agent

BBC oral spraydrug

Topical anesthetics and anti-inflammatory agent

Oracure geldrug

Topical analgesic gel

Alkamisr sachetsother

Sodium bicarbonate mouthwash